Rchr
J-GLOBAL ID：201101000826869395
Update date: Sep. 10, 2024
Imaizumi Satoshi
イマイズミ サトシ | Imaizumi Satoshi
Affiliation and department：
Research field (1)：
Internal medicine - General
Research theme for competitive and other funds (6)：
Papers (113)：
-
Kohei Takata, Satoshi Imaizumi, Atsushi Iwata, Bo Zhang, Emi Kawachi, Shin-Ichiro Miura, Masahiro Ogawa. Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis. Biomolecules. 2023. 13. 9
-
Hang Zhang, Tomohiro Komatsu, Shihoko Nakashima, Satomi Abe, Emi Kawachi, Satoshi Imaizumi, Keijiro Saku, Yoshinari Uehara. HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α. European Cardiology Review. 2023. 18
-
Shin-ichiro Miura, Yasunori Suematsu, Satoshi Imaizumi, Eiji Yahiro, Takashi Kuwano, Yoshinari Uehara, Keijiro Saku. Apolipoprotein A-I Mimetics for Treatment of the Residual Risk of Cardiovascular Disease. CardioMetabolic Syndrome Journal. 2021. 1. 2. 135-144
-
Satoshi Imaizumi, Yuhei Shiga, Masahiro Ogawa, Hideto Sako, Yoshihisa Nagata, Akira Matsunaga, Tetsuro Shirotani, Fumihiro Hoshino, Eiji Yahiro, Yuko Uehara, et al. Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study. Heart and vessels. 2020. 35. 4. 603-604
-
今泉聡, 池周而. ApoA-I模倣ペプチドFAMPと超音波/マイクロバブルを併用した新規動脈硬化治療. 福岡大学研究部論集. 2019
ｍore...
MISC (21)：
-
S. Imaizumi, K. Takata, E. Yahiro, E. Kawachi, A. Iwata, Y. Uehara, B. Zhang, S. Miura, K. Saku. Inhibition of lipopolysaccharide induced gene expression by HDL from healthy subjects and patients with acute myocardial infarction. EUROPEAN HEART JOURNAL. 2016. 37. 217-218
-
Y. Hitaka, M. Ogawa, S. Goto, Y. Nagata, J. Morii, S. Imaizumi, T. Yasuda, N. Matsumoto, A. Matsunaga, K. Saku. Comparison of circadian laboratory measurements of coagulation assays between administrations of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation. EUROPEAN HEART JOURNAL. 2015. 36. 225-225
-
K. Takata, A. Iwata, S. Imaizumi, B. Zhang, S. Miura, K. Saku. Impact of anti-oxidative capacity of high-density lipoprotein on vulnerability of coronary plaques in patients with type 2 diabetes mellitus. EUROPEAN HEART JOURNAL. 2015. 36. 346-346
-
S. Imaizumi, A. Iwata, K. Takata, B. Zhang, S. Miura, K. Saku. Relation between high-density lipoprotein efflux capacity and coronary plaque progression in type 2 diabetes patients with intensive lipid-lowering therapy. EUROPEAN HEART JOURNAL. 2015. 36. 812-812
-
E. Kawachi, S. Imaizumi, K. Takata, S. Abe, Y. Matsuo, E. Yahiro, Y. Uehara, B. Zhang, S. Miura, K. Saku. Effect of smoking cessation on HDL function. EUROPEAN HEART JOURNAL. 2014. 35. 902-902
ｍore...
Books (9)：
-
10. 日本医師会 生涯教育シリーズ97 動脈硬化診療のすべて IV. 動脈硬化研究のトピックス A. 基礎研究 3. カナキヌマブ
日本医師会 2019
-
循環器疾患 最新の治療2018-2019 XVI 3.脂質異常症(高脂血症)
2018
-
最新冠動脈疾患学(下)-冠動脈疾患の最新治療戦略- 4. 慢性心筋梗塞 (2)慢性心筋梗塞の治療 1)薬物療法 2二次予防薬
2016
-
そうだったんだ!脂質異常症 I. One Point Advice. 高HDL血症は高リスク?
2016
-
そうだったんだ!脂質異常症 I. Controversy. 飲酒でHDLが増加する?
2016
ｍore...
Professional career (2)：
Return to Previous Page
